A human proto-oncogene located on chromosome 9. The designation is taken from name of the scientist, Herbert Abelson MD, who discovered the gene. ABL1 activates a number of cell cycle-controlling proteins and enzymes. Mutations in the ABL1 gene are associated with chronic myelogenous leukaemia (CML).